scholarly journals The Impact of Reinterventions on Survival After Fenestrated and Branched Endovascular Aneurysm Repair

2020 ◽  
Vol 72 (1) ◽  
pp. e48
Author(s):  
Enrico Gallitto ◽  
Gianluca Faggioli ◽  
Cecilia Fenelli ◽  
Chiara Mascoli ◽  
Rodolfo Pini ◽  
...  
2021 ◽  
Vol 142 ◽  
pp. 110367
Author(s):  
Yarrow Scantling-Birch ◽  
Guy Martin ◽  
Sathyan Balaji ◽  
Jacqueline Trant ◽  
Ian Nordon ◽  
...  

2019 ◽  
Vol 70 (4) ◽  
pp. 1380
Author(s):  
E.R. Charles ◽  
D. Lui ◽  
J. Delf ◽  
R.D. Sayers ◽  
M.J. Bown ◽  
...  

Vascular ◽  
2008 ◽  
Vol 16 (6) ◽  
pp. 340-345 ◽  
Author(s):  
Umar Sadat ◽  
David G. Cooper ◽  
Jonathan H. Gillard ◽  
Stewart R. Walsh ◽  
Paul D. Hayes

The type of anesthesia used during aneurysm repair affects postoperative outcomes for the patient. Although endovascular aneurysm repair (EVAR) appears to improve surgical outcomes, by convention, general anesthesia remains predominantly used. The aim of this study was to compare the impact of the type of anesthesia (ie, locoregional versus general anesthesia) on the outcomes following EVAR. A literature search was carried out using the PubMed search engine to find relevant published articles that compared locoregional and general anesthesia in patients undergoing EVAR. The review of the selected studies showed that although patients in the locoregional group were less medically fit compared with those in the general anesthesia group, there was a reduction in the cardiovascular support required during and after the surgery, postoperative hospital stay, intensive care unit (ICU) stay, and postoperative mortality and morbidity. Although there is no level 1 evidence for or against locoregional anesthesia in EVAR, conventionally, EVAR has been performed under general anesthesia. But this is rooted in tradition rather than evidence. This review suggests that locoregional anesthesia can improve postoperative outcomes following EVAR by reducing hospital stay, ICU stay, mortality, and morbidity, although other factors may also have some influence.


2017 ◽  
Vol 65 (6) ◽  
pp. 149S
Author(s):  
Jennifer C. Grom ◽  
Rami O. Tadros ◽  
Melissa Baldwin ◽  
Martin Kang ◽  
Daniel K. Han ◽  
...  

2018 ◽  
Vol 56 (6) ◽  
pp. e29
Author(s):  
Edmund R. Charles ◽  
Dennis Lui ◽  
Jonathan Delf ◽  
Robert D. Sayers ◽  
Matthew J. Bown ◽  
...  

Vascular ◽  
2021 ◽  
pp. 170853812110633
Author(s):  
Selami Gurkan ◽  
Ozcan Gur ◽  
Ayhan Sahin ◽  
Mehmet Donbaloglu

Background Obesity is a common and growing health problem in vascular surgery patients, as it is in all patient groups. Evidence regarding body mass index (BMI) on endovascular aneurysm repair (EVAR) outcomes is not clear in the literature. We aimed to determine the impact of obesity on perioperative and midterm outcomes of elective EVAR between obese and non-obese patients. Methods Under a retrospective study design, a total of 120 patients (109 males, 11 females, mean age: 74.45 ± 8.59 (53–92 years)) undergoing elective EVAR between June 2012 and May 2020 were reviewed. Patients were stratified into two groups: obese (defined as a body mass index (BMI) ≥ 30 kg/m2) and non-obese (mean BMI < 30 kg/m2 (32.25 ± 1.07 kg/m2 vs 25.85 ± 2.69 kg/m2)). Results Of the 120 patients included in the study, 81 (67.5%) were defined as “nonobese,” while 39 (32.5%) were obese. The mean BMI of the study group was 27.93 ± 3.78 kg/m2. In obese patients, the procedure time, fluoroscopy time, and dose area product (DAP) values were longer than those of non-obese patients: 89.74 ± 20.54 vs 79.69 ± 28.77 min ( p = 0.035), 33.23 ± 10.14 vs 38.17 ± 8.61 min ( p = 0.01) and 133.69 ± 58.17 vs 232.56 ± 51.87 Gy.cm2 ( p < 0.001). Although there was no difference in sac shrinkage at 12-month follow-up, there was a significant decrease at 6-month follow-up in both groups ( p = 0.017). Endoleak occurred in 17.9% ( n = 7) of the obese group versus 11.1% ( n = 9) of the non-obese group ( p = 0.302). Iliac branch occlusion developed in four patients, 3 (3.7%) in the non-obese group and 1 (2.6%) in the obese group ( p = 0.608). The all-cause mortality rate was slightly higher in the obese group; however, it did not differ between the groups ( p = 0.463). Conclusion In addition to the longer procedure times, fluoroscopy times, and DAP values in obese patients, regardless of obesity, significant sac shrinkage in the first 6 months of follow-up was observed in both groups. No difference was documented with regards to mortality or morbidity following EVAR.


2010 ◽  
Vol 52 (2) ◽  
pp. 298-302 ◽  
Author(s):  
Claire Jones ◽  
Stephen A. Badger ◽  
Christopher S. Boyd ◽  
Chee V. Soong

2014 ◽  
Vol 60 (3) ◽  
pp. 585-589 ◽  
Author(s):  
James Coulston ◽  
Amy Baigent ◽  
Haran Selvachandran ◽  
Steven Jones ◽  
Francesco Torella ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document